Literature DB >> 35505014

The Chicken Embryo Chorioallantoic Membrane as an In Vivo Model for Photodynamic Therapy.

Jaroslava Joniová1, Georges Wagnières2.   

Abstract

For many decades the chicken embryo chorioallantoic membrane (CAM) has been used for research as an in vivo model in a large number of different fields, including toxicology, bioengineering, and cancer research. More specifically, the CAM is also a suitable and convenient model system in the field of photodynamic therapy (PDT), mainly due to the easy access of its membrane and the possibility of grafting or growing tumors on the membrane and, interestingly, to study the PDT effects on its dense vascular network. In addition, the CAM is simple to handle and cheap. Since the CAM is not innervated until later stages of the embryo development, its use in research is simplified compared to other in vivo models as far as ethical and regulatory issues are concerned. In this review different incubation and drug administration protocols of relevance for PDT are presented. Moreover, data regarding the propagation of light at different wavelengths and CAM development stages are provided. Finally, the effects induced by photobiomodulation on the CAM angiogenesis and its impact on PDT treatment outcome are discussed.
© 2022. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Angiogenesis; CAM; Chicken embryo chorioallantoic membrane; Model system; PDT; Photodynamic therapy; Vascular network; Xenograft

Mesh:

Year:  2022        PMID: 35505014     DOI: 10.1007/978-1-0716-2099-1_9

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  84 in total

1.  The first evidence of the tumor-induced angiogenesis in vivo by using the chorioallantoic membrane assay dated 1913.

Authors:  Domenico Ribatti
Journal:  Leukemia       Date:  2004-08       Impact factor: 11.528

Review 2.  Laboratory environments and rodents' behavioural needs: a review.

Authors:  J P Balcombe
Journal:  Lab Anim       Date:  2006-07       Impact factor: 2.471

Review 3.  The chick embryo chorioallantoic membrane as a model for tumor biology.

Authors:  Domenico Ribatti
Journal:  Exp Cell Res       Date:  2014-06-24       Impact factor: 3.905

4.  Stress-like responses to common procedures in individually and group-housed female rats.

Authors:  Jody Sharp; Timothy Zammit; Toni Azar; David Lawson
Journal:  Contemp Top Lab Anim Sci       Date:  2003-01

Review 5.  The chick embryo and its chorioallantoic membrane (CAM) for the in vivo evaluation of drug delivery systems.

Authors:  Angelica Vargas; Magali Zeisser-Labouèbe; Norbert Lange; Robert Gurny; Florence Delie
Journal:  Adv Drug Deliv Rev       Date:  2007-08-16       Impact factor: 15.470

Review 6.  Chick chorioallantoic membrane as an in situ biological membrane for pharmaceutical formulation development: a review.

Authors:  Constance L L Saw; Paul W S Heng; Celine V Liew
Journal:  Drug Dev Ind Pharm       Date:  2008-11       Impact factor: 3.225

Review 7.  * The Chorioallantoic Membrane Assay for Biomaterial Testing in Tissue Engineering: A Short-Term In Vivo Preclinical Model.

Authors:  Inés Moreno-Jiménez; Janos M Kanczler; Gry Hulsart-Billstrom; Stefanie Inglis; Richard O C Oreffo
Journal:  Tissue Eng Part C Methods       Date:  2017-10-20       Impact factor: 3.056

8.  Chick embryo chorioallantoic membrane (CAM): an alternative predictive model in acute toxicological studies for anti-cancer drugs.

Authors:  Chin Siang Kue; Kae Yi Tan; May Lynn Lam; Hong Boon Lee
Journal:  Exp Anim       Date:  2015-01-22

9.  Development of bioluminescent chick chorioallantoic membrane (CAM) models for primary pancreatic cancer cells: a platform for drug testing.

Authors:  Maria Rovithi; Amir Avan; Niccola Funel; Leticia G Leon; Valentina E Gomez; Thomas Wurdinger; Arjan W Griffioen; Henk M W Verheul; Elisa Giovannetti
Journal:  Sci Rep       Date:  2017-03-17       Impact factor: 4.379

10.  TRANSPLANTABILITY OF TISSUES TO THE EMBRYO OF FOREIGN SPECIES : ITS BEARING ON QUESTIONS OF TISSUE SPECIFICITY AND TUMOR IMMUNITY.

Authors:  J B Murphy
Journal:  J Exp Med       Date:  1913-04-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.